| 000 | 01877 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250518095609.0 | ||
| 264 | 0 | _c20201112 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/acs.jmedchem.0c00278 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aŠála, Michal | |
| 245 | 0 | 0 |
_aNovel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _c06 2020 |
||
| 300 |
_a6028-6056 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aExosomes _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aPyridazines _xchemistry |
| 650 | 0 | 4 |
_aSphingomyelin Phosphodiesterase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aHollinger, Kristen R | |
| 700 | 1 | _aThomas, Ajit G | |
| 700 | 1 | _aDash, Ranjeet P | |
| 700 | 1 | _aTallon, Carolyn | |
| 700 | 1 | _aVeeravalli, Vijayabhaskar | |
| 700 | 1 | _aLovell, Lyndah | |
| 700 | 1 | _aKögler, Martin | |
| 700 | 1 | _aHřebabecký, Hubert | |
| 700 | 1 | _aProcházková, Eliška | |
| 700 | 1 | _aNešuta, Ondřej | |
| 700 | 1 | _aDonoghue, Amanda | |
| 700 | 1 | _aLam, Jenny | |
| 700 | 1 | _aRais, Rana | |
| 700 | 1 | _aRojas, Camilo | |
| 700 | 1 | _aSlusher, Barbara S | |
| 700 | 1 | _aNencka, Radim | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 63 _gno. 11 _gp. 6028-6056 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.jmedchem.0c00278 _zAvailable from publisher's website |
| 999 |
_c30865479 _d30865479 |
||